P1.01-23 High PD-L1 Expression is Less Common Than Expected Among Advanced NSCLC in Brazil. Are We Missing the Target? von Gelatti, A., Cordeiro De Lima, V., Freitas, H., Werutsky, G., Gaiger, A.M., Klock, C., Viola, P., Shiang, C., De Macedo, M., Lopes, L., Zaffaroni, F., Araujo, L.H., Mascarenhas, E., Mathias, C., Moura, F., Borges, G., Barrios, C., Zukin, M.

Volltext

Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases von Garcia, V.D, Bonamigo-Filho, J.S, Neumann, J, Fogliatto, L, Gaiger, A.M, Garcia, C.D, Barros, V, Keitel, E, Bittar, A.E, Santos, A.F, Roithmann, S

Volltext